Tirzepatide, this innovative medication, is sparking considerable buzz within the healthcare community. It functions differently from common diabetes therapies , targeting both receptors involved in blood regulation and satiety. Initial research have demonstrated significant efficacy in lowering blood glucose in individuals with type 2 diabetes and